Medtronic (MDT) Cash from Investing Activities Growth (3y) (2017 - 2026)

Medtronic (MDT) Cash from Investing Activities Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -253.01%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -11.91%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -41.67%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -111.03%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -40.94%
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -2.10%

Historic Data

Download Data
DateValue
Jan 23, 2026 -41.67%
Oct 24, 2025 25.08%
Jul 25, 2025 23.16%
Apr 25, 2025 -56.16%
Jan 24, 2025 -24.48%
Oct 25, 2024 21.35%
Jul 26, 2024 30.87%
Apr 26, 2024 -33.19%
Jan 26, 2024 36.59%
Oct 27, 2023 40.57%
Jul 28, 2023 -310.90%
Apr 28, 2023 -48.90%
Jan 27, 2023 45.78%
Oct 28, 2022 1.96%
Jul 29, 2022 -42.22%
Apr 29, 2022 35.94%
Jan 28, 2022 24.34%
Oct 29, 2021 -98.82%
Jul 30, 2021 -47.66%
Apr 30, 2021 158.57%